Wockhardt stock soars over 19% after its investigational antibiotic Zaynich successfully treats cancer patient in US

This marked the first instance in US, where Zaynich had been used to combat a complex infection caused by extreme-drug-resistant pseudomonas

Subscribe To Our Free Newsletter